Steven C Gilman Akebia Therapeutics, Inc. (AKBA) insider trading activity

AKBA Quotes by TradingView

Steven C Gilman is of Akebia Therapeutics, Inc.. Currently has a direct ownership of 117,130 shares of AKBA, which is worth approximately $228,403. The most recent transaction as insider was on Jun 06, 2024, when has been sold 30,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 117K
0% 3M change
34.43% 12M change
Total Value Held $228,403

STEVEN C GILMAN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 06 2024
BUY
Grant, award, or other acquisition
-
30,000 Added 20.39%
117,130 Common Stock
Jun 06 2023
BUY
Grant, award, or other acquisition
-
30,000 Added 25.61%
87,130 Common Stock
Jun 08 2022
BUY
Grant, award, or other acquisition
-
13,700 Added 19.34%
57,130 Common Stock
Jun 03 2022
SELL
Open market or private sale
$1,644 $0.36 p/Share
4,567 Reduced 9.52%
43,430 Common Stock
Jun 07 2021
SELL
Open market or private sale
$15,162 $3.32 p/Share
4,567 Reduced 8.69%
47,997 Common Stock
Jun 02 2021
BUY
Grant, award, or other acquisition
-
13,700 Added 20.67%
52,564 Common Stock

Also insider at

SCYX
SCYNEXIS INC Healthcare
VCEL
Vericel Corp Healthcare
CFRX
CONTRAFECT Corp Healthcare
Director
SCG

Steven C Gilman

Cambridge, MA

Track Institutional and Insider Activities on AKBA

Follow Akebia Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKBA shares.

Notify only if

Insider Trading

Get notified when an Akebia Therapeutics, Inc. insider buys or sells AKBA shares.

Notify only if

News

Receive news related to Akebia Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AKBA